You will receive alerts when there are new announcements on AMBRILIA BIOPHARMA
Only registered members can use this feature.
A biopharmaceutical company dedicated to the discovery and development of novel treatments for viral diseases and cancerIts product portfolio includes an HIV protease inhibitor program as well as other anti-viral programs.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.